Qingdao Baheal Medical INC. financials at a glance
| Year | Year | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
¥5.88B | ¥7.05B | ¥7.51B | ¥7.56B | ¥0.00M |
| GM % | Gross Margin % |
|
24.90% | 25.16% | 27.75% | 29.98% | 0.00% |
| OM | Operating Margin |
|
7.05% | 8.72% | 9.49% | 12.40% | 0.00% |
| EPS | Earnings Per Share |
|
¥1.19 | ¥0.00 | |||
| Div. | Dividends |
|
¥0.00 | ¥0.00 | ¥0.00 | ¥0.76 | ¥0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 63.87% | 0 |
| Sha. | Shares |
|
0m | 525.1m | 525.1m | 0m | 525.61m |
| OCF | Operating Cash Flow |
|
¥-116.83M | ¥181.30M | ¥305.75M | ¥609.70M | ¥0.00M |
| FCF | Free Cash Flow |
|
¥-133.18M | ¥153.81M | ¥200.43M | ¥480.46M | ¥0.00M |
| FCFS | Free Cash Flow Per Share |
|
¥-0.28 | ¥0.31 | ¥0.38 | ¥0.92 | ¥0.00 |